Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Acq. announced
Consulting agrmnt
Director departure
Appointed director
|
|
PANACEA LIFE SCIENCES HOLDINGS, INC. (EXDI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/17/2021 |
8-K/A
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Audited financial statements of Panacea Life Sciences, Inc. for the years ended December 31, 2020 and 2019 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Panacea Life Sciences, Inc. Opinion on the Financial Statements We have audited the accompanying balance sheets of Panacea Life Sciences, Inc. as of December 31, 2020 and 2019, and the related statements of operations, stockholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2020, and the related notes . In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the years in the two-...",
"Unaudited pro forma condensed combined financial information On June 30, 2021, Panacea Life Sciences Holdings, Inc. acquired Panacea Life Sciences, Inc. pursuant to a Securities Exchange Agreement with the shareholders of Panacea including its founder Leslie Buttorff and 22nd Century Group, Inc., , a principal investor. All share amounts have been retroactively adjusted to give effect to the 1-for-28 reverse stock split of EXDI’ s common stock which was effected on October 25, 2021 ." |
|
| 03/17/2020 |
8-K/A
| Quarterly results |
| 01/22/2019 |
8-K/A
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Depart... |
|
|